Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023
2023年11月3日 - 5:05AM
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial
stage biotechnology company that aims to translate the genetics of
the adaptive immune system into clinical products to diagnose and
treat disease, today announced it will report financial results for
the third quarter of 2023 after market close on Thursday, November
9, 2023. Company management will webcast a corresponding conference
call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on
the “Investors” section of the company website at:
www.adaptivebiotech.com. The webcast will be archived and available
for replay within 24 hours after the event.
About Adaptive
Biotechnologies
Adaptive Biotechnologies is a commercial-stage
biotechnology company focused on harnessing the inherent biology of
the adaptive immune system to transform the diagnosis and treatment
of disease. We believe the adaptive immune system is nature’s most
finely tuned diagnostic and therapeutic for most diseases, but the
inability to decode it has prevented the medical community from
fully leveraging its capabilities. Our proprietary immune medicine
platform reveals and translates the massive genetics of the
adaptive immune system with scale, precision and speed to develop
products in our Immune Medicine and Minimal Residual Disease (MRD)
businesses. For more information, please
visit adaptivebiotech.com and follow us on
www.twitter.com/adaptivebiotech.
ADAPTIVE INVESTORSKarina
Calzadilla, Vice President, Investor
Relations201-396-1687investors@adaptivebiotech.com
ADAPTIVE MEDIAErica Jones,
Associate Corporate Communications
206-279-2423media@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
過去 株価チャート
から 4 2024 まで 5 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
過去 株価チャート
から 5 2023 まで 5 2024